Compounds > hemoregulatory peptide 5b
Page last updated: 2024-09-03

hemoregulatory peptide 5b and ammonium trichloro(dioxoethylene-o,o'-)tellurate

hemoregulatory peptide 5b has been researched along with ammonium trichloro(dioxoethylene-o,o'-)tellurate in 1 studies

Compound Research Comparison

Studies
(hemoregulatory peptide 5b)		Trials
(hemoregulatory peptide 5b)		Recent Studies (post-2010)
(hemoregulatory peptide 5b)		Studies
(ammonium trichloro(dioxoethylene-o,o'-)tellurate)		Trials
(ammonium trichloro(dioxoethylene-o,o'-)tellurate)		Recent Studies (post-2010) (ammonium trichloro(dioxoethylene-o,o'-)tellurate)
430299527

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guest, I; Uetrecht, J1

Reviews

1 review(s) available for hemoregulatory peptide 5b and ammonium trichloro(dioxoethylene-o,o'-)tellurate

ArticleYear
Bone marrow stem cell protection from chemotherapy by low--molecular-weight compounds.
    Experimental hematology, 2001, Volume: 29, Issue:2

    Topics: Amifostine; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow Cells; Ethylenes; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Leukopenia; MEDLINE; Molecular Weight; Oligopeptides; Pyrrolidonecarboxylic Acid; Thrombocytopenia

2001